Absci ABSI
NASDAQ ABSI
$8.97 +0.17 (+1.93%)
As of: Sep 4, 2026 · 11:51 AM EDT

Absci (ABSI) Other Non Operating Income (2020 - 2026)

Absci (ABSI) posted Other Non Operating Income of $1.3 million for Q1 2026, down 4.68% sequentially from $1.3 million in Q4 2025, and down 12.0% YoY from $1.5 million in Q1 2025.

Analysis

Absci (ABSI) Other Non Operating Income (2020 - 2026) Analysis & Trends

Absci has reported Other Non Operating Income for 7 years, with the latest figure at $1.3 million in Q1 2026.

  • Quarterly Other Non Operating Income fell 12.0% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 15.04% YoY) and the FY2025 annual result came in at $5.4 million, down 15.66% from the prior year.
  • Other Non Operating Income declined to $1.3 million in Q1 2026 per ABSI's latest filing, from $1.3 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $2.1 million in Q2 2024 and troughed at $125000.0 in Q1 2022.
  • A 5-year average of $1.3 million and a median of $1.4 million in 2023 frame the typical range for Other Non Operating Income.
  • The sharpest annual moves came in 2023 and 2025: Other Non Operating Income jumped 1066.4% in 2023, then tumbled 52.33% in 2025.
  • Over 5 years, Other Non Operating Income stood at $1.4 million in 2022, then climbed by 2.63% to $1.4 million in 2023, then plunged by 36.31% to $921000.0 in 2024, then soared by 46.15% to $1.3 million in 2025, then slipped by 4.68% to $1.3 million in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $1.3 million, $1.3 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn -
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn
10 Absci 1.41 Bn 1.21 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 990,000.00
Mar 31, 2026 1.28 Mn
Dec 31, 2025 1.35 Mn
Sep 30, 2025 1.60 Mn
Jun 30, 2025 1.01 Mn
Mar 31, 2025 1.46 Mn
Dec 31, 2024 921,000.00
Sep 30, 2024 1.66 Mn
Jun 30, 2024 2.12 Mn
Mar 31, 2024 1.71 Mn
Dec 31, 2023 1.45 Mn
Sep 30, 2023 1.57 Mn
Jun 30, 2023 1.58 Mn
Mar 31, 2023 1.46 Mn
Dec 31, 2022 1.41 Mn
Sep 30, 2022 675,000.00
Jun 30, 2022 148,000.00
Mar 31, 2022 125,000.00
Dec 31, 2021 188,000.00
Sep 30, 2021 -3.43 Mn